SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SRF
|
ENSG00000112658.6 | serum response factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SRF | hg19_v2_chr6_+_43139037_43139094 | 0.37 | 1.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_+_137801160 | 50.38 |
ENST00000239938.4
|
EGR1
|
early growth response 1 |
chr18_+_61143994 | 8.10 |
ENST00000382771.4
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
chr14_+_75745477 | 6.90 |
ENST00000303562.4
ENST00000554617.1 ENST00000554212.1 ENST00000535987.1 ENST00000555242.1 |
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
chr19_+_16177826 | 6.22 |
ENST00000589897.1
|
TPM4
|
tropomyosin 4 |
chr12_+_4382917 | 5.96 |
ENST00000261254.3
|
CCND2
|
cyclin D2 |
chr2_-_161056762 | 4.85 |
ENST00000428609.2
ENST00000409967.2 |
ITGB6
|
integrin, beta 6 |
chr2_-_161056802 | 4.63 |
ENST00000283249.2
ENST00000409872.1 |
ITGB6
|
integrin, beta 6 |
chr19_+_45971246 | 4.61 |
ENST00000585836.1
ENST00000417353.2 ENST00000353609.3 ENST00000591858.1 ENST00000443841.2 ENST00000590335.1 |
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B |
chr3_-_99594948 | 4.20 |
ENST00000471562.1
ENST00000495625.2 |
FILIP1L
|
filamin A interacting protein 1-like |
chr1_-_89531041 | 3.64 |
ENST00000370473.4
|
GBP1
|
guanylate binding protein 1, interferon-inducible |
chr3_-_99595037 | 3.49 |
ENST00000383694.2
|
FILIP1L
|
filamin A interacting protein 1-like |
chr5_+_150404904 | 3.48 |
ENST00000521632.1
|
GPX3
|
glutathione peroxidase 3 (plasma) |
chr12_-_15104040 | 3.47 |
ENST00000541644.1
ENST00000545895.1 |
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr17_+_30089454 | 3.26 |
ENST00000577970.1
|
RP11-805L22.3
|
RP11-805L22.3 |
chr10_-_64576105 | 3.26 |
ENST00000242480.3
ENST00000411732.1 |
EGR2
|
early growth response 2 |
chr20_+_35169885 | 3.11 |
ENST00000279022.2
ENST00000346786.2 |
MYL9
|
myosin, light chain 9, regulatory |
chr12_-_50616122 | 3.03 |
ENST00000552823.1
ENST00000552909.1 |
LIMA1
|
LIM domain and actin binding 1 |
chr8_+_97597148 | 2.96 |
ENST00000521590.1
|
SDC2
|
syndecan 2 |
chr14_-_94443105 | 2.86 |
ENST00000555019.1
|
ASB2
|
ankyrin repeat and SOCS box containing 2 |
chr12_-_50616382 | 2.84 |
ENST00000552783.1
|
LIMA1
|
LIM domain and actin binding 1 |
chr4_+_87928140 | 2.77 |
ENST00000307808.6
|
AFF1
|
AF4/FMR2 family, member 1 |
chr3_-_121379739 | 2.70 |
ENST00000428394.2
ENST00000314583.3 |
HCLS1
|
hematopoietic cell-specific Lyn substrate 1 |
chr1_-_91487806 | 2.51 |
ENST00000361321.5
|
ZNF644
|
zinc finger protein 644 |
chr11_-_65667884 | 2.28 |
ENST00000448083.2
ENST00000531493.1 ENST00000532401.1 |
FOSL1
|
FOS-like antigen 1 |
chr19_+_13135386 | 2.22 |
ENST00000360105.4
ENST00000588228.1 ENST00000591028.1 |
NFIX
|
nuclear factor I/X (CCAAT-binding transcription factor) |
chr19_+_1026298 | 2.13 |
ENST00000263097.4
|
CNN2
|
calponin 2 |
chr15_+_96873921 | 2.13 |
ENST00000394166.3
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
chr5_+_66254698 | 2.04 |
ENST00000405643.1
ENST00000407621.1 ENST00000432426.1 |
MAST4
|
microtubule associated serine/threonine kinase family member 4 |
chr17_+_50939459 | 2.04 |
ENST00000412360.1
|
AC102948.2
|
Uncharacterized protein |
chr11_-_65667997 | 2.02 |
ENST00000312562.2
ENST00000534222.1 |
FOSL1
|
FOS-like antigen 1 |
chr5_-_142000883 | 1.98 |
ENST00000359370.6
|
FGF1
|
fibroblast growth factor 1 (acidic) |
chr19_+_57901208 | 1.92 |
ENST00000366197.5
ENST00000596282.1 ENST00000597400.1 ENST00000598895.1 ENST00000336128.7 ENST00000596617.1 |
ZNF548
AC003002.6
|
zinc finger protein 548 Uncharacterized protein |
chr9_+_124088860 | 1.82 |
ENST00000373806.1
|
GSN
|
gelsolin |
chr4_-_87028478 | 1.80 |
ENST00000515400.1
ENST00000395157.3 |
MAPK10
|
mitogen-activated protein kinase 10 |
chr4_+_87928353 | 1.79 |
ENST00000511722.1
|
AFF1
|
AF4/FMR2 family, member 1 |
chr1_-_91487770 | 1.77 |
ENST00000337393.5
|
ZNF644
|
zinc finger protein 644 |
chr1_+_16085244 | 1.72 |
ENST00000400773.1
|
FBLIM1
|
filamin binding LIM protein 1 |
chr7_+_143078652 | 1.67 |
ENST00000354434.4
ENST00000449423.2 |
ZYX
|
zyxin |
chr9_+_92219919 | 1.67 |
ENST00000252506.6
ENST00000375769.1 |
GADD45G
|
growth arrest and DNA-damage-inducible, gamma |
chr22_+_38004723 | 1.64 |
ENST00000381756.5
|
GGA1
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 1 |
chr22_+_38004832 | 1.63 |
ENST00000405147.3
ENST00000429218.1 ENST00000325180.8 ENST00000337437.4 |
GGA1
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 1 |
chr19_+_1026566 | 1.62 |
ENST00000348419.3
ENST00000565096.2 ENST00000562958.2 ENST00000562075.2 ENST00000607102.1 |
CNN2
|
calponin 2 |
chr22_+_38004473 | 1.55 |
ENST00000414350.3
ENST00000343632.4 |
GGA1
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 1 |
chr19_+_13134772 | 1.55 |
ENST00000587760.1
ENST00000585575.1 |
NFIX
|
nuclear factor I/X (CCAAT-binding transcription factor) |
chr4_+_87928413 | 1.52 |
ENST00000544085.1
|
AFF1
|
AF4/FMR2 family, member 1 |
chr9_+_131644781 | 1.49 |
ENST00000259324.5
|
LRRC8A
|
leucine rich repeat containing 8 family, member A |
chr12_+_75874580 | 1.48 |
ENST00000456650.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
chr19_-_15344243 | 1.36 |
ENST00000602233.1
|
EPHX3
|
epoxide hydrolase 3 |
chr3_-_71294304 | 1.29 |
ENST00000498215.1
|
FOXP1
|
forkhead box P1 |
chr5_-_124080203 | 1.27 |
ENST00000504926.1
|
ZNF608
|
zinc finger protein 608 |
chr13_-_46742630 | 1.24 |
ENST00000416500.1
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
chr19_-_15343773 | 1.20 |
ENST00000435261.1
ENST00000594042.1 |
EPHX3
|
epoxide hydrolase 3 |
chr6_+_43139037 | 1.17 |
ENST00000265354.4
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor) |
chr19_+_54372877 | 1.17 |
ENST00000414489.1
|
MYADM
|
myeloid-associated differentiation marker |
chr1_+_16085263 | 1.12 |
ENST00000483633.2
ENST00000502739.1 ENST00000431771.2 |
FBLIM1
|
filamin binding LIM protein 1 |
chr15_+_74218787 | 1.11 |
ENST00000261921.7
|
LOXL1
|
lysyl oxidase-like 1 |
chr8_-_22550815 | 1.06 |
ENST00000317216.2
|
EGR3
|
early growth response 3 |
chr2_-_31030277 | 1.06 |
ENST00000534090.2
ENST00000295055.8 |
CAPN13
|
calpain 13 |
chr19_-_36247910 | 1.06 |
ENST00000587965.1
ENST00000004982.3 |
HSPB6
|
heat shock protein, alpha-crystallin-related, B6 |
chr8_+_125954281 | 1.05 |
ENST00000510897.2
ENST00000533286.1 |
LINC00964
|
long intergenic non-protein coding RNA 964 |
chr1_-_89591749 | 1.02 |
ENST00000370466.3
|
GBP2
|
guanylate binding protein 2, interferon-inducible |
chr22_-_36784035 | 1.02 |
ENST00000216181.5
|
MYH9
|
myosin, heavy chain 9, non-muscle |
chr4_+_189321881 | 1.01 |
ENST00000512839.1
ENST00000513313.1 |
LINC01060
|
long intergenic non-protein coding RNA 1060 |
chr17_-_4890919 | 0.99 |
ENST00000572543.1
ENST00000381311.5 ENST00000348066.3 ENST00000358183.4 |
CAMTA2
|
calmodulin binding transcription activator 2 |
chrX_+_22056165 | 0.96 |
ENST00000535894.1
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked |
chr5_+_40679584 | 0.89 |
ENST00000302472.3
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4) |
chr13_+_27825706 | 0.88 |
ENST00000272274.4
ENST00000319826.4 ENST00000326092.4 |
RPL21
|
ribosomal protein L21 |
chr11_-_71823715 | 0.85 |
ENST00000545944.1
ENST00000502597.2 |
ANAPC15
|
anaphase promoting complex subunit 15 |
chr12_+_75874460 | 0.84 |
ENST00000266659.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
chr4_+_186064395 | 0.82 |
ENST00000281456.6
|
SLC25A4
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
chr17_-_27949911 | 0.81 |
ENST00000492276.2
ENST00000345068.5 ENST00000584602.1 |
CORO6
|
coronin 6 |
chr18_+_54318616 | 0.79 |
ENST00000254442.3
|
WDR7
|
WD repeat domain 7 |
chr19_+_52102540 | 0.77 |
ENST00000601315.1
|
AC018755.17
|
AC018755.17 |
chr19_+_54372639 | 0.72 |
ENST00000391769.2
|
MYADM
|
myeloid-associated differentiation marker |
chr19_-_35166604 | 0.71 |
ENST00000601241.1
|
SCGB2B2
|
secretoglobin, family 2B, member 2 |
chr7_-_5570229 | 0.69 |
ENST00000331789.5
|
ACTB
|
actin, beta |
chr18_+_54318566 | 0.66 |
ENST00000589935.1
ENST00000357574.3 |
WDR7
|
WD repeat domain 7 |
chr5_-_179050660 | 0.66 |
ENST00000519056.1
ENST00000506721.1 ENST00000503105.1 ENST00000504348.1 ENST00000508103.1 ENST00000510431.1 ENST00000515158.1 ENST00000393432.4 ENST00000442819.2 |
HNRNPH1
|
heterogeneous nuclear ribonucleoprotein H1 (H) |
chr18_-_54318353 | 0.65 |
ENST00000590954.1
ENST00000540155.1 |
TXNL1
|
thioredoxin-like 1 |
chr9_+_140772226 | 0.64 |
ENST00000277551.2
ENST00000371372.1 ENST00000277549.5 ENST00000371363.1 ENST00000371357.1 ENST00000371355.4 |
CACNA1B
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
chr11_-_2162468 | 0.61 |
ENST00000434045.2
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr12_-_6772303 | 0.60 |
ENST00000396807.4
ENST00000446105.2 ENST00000341550.4 |
ING4
|
inhibitor of growth family, member 4 |
chr7_+_88388628 | 0.60 |
ENST00000333190.4
|
ZNF804B
|
zinc finger protein 804B |
chr2_+_101179152 | 0.60 |
ENST00000264254.6
|
PDCL3
|
phosducin-like 3 |
chr16_+_30077098 | 0.59 |
ENST00000395240.3
ENST00000566846.1 |
ALDOA
|
aldolase A, fructose-bisphosphate |
chr11_+_12108410 | 0.56 |
ENST00000527997.1
|
RP13-631K18.5
|
RP13-631K18.5 |
chr5_-_176923846 | 0.55 |
ENST00000506537.1
|
PDLIM7
|
PDZ and LIM domain 7 (enigma) |
chr6_-_159466136 | 0.54 |
ENST00000367066.3
ENST00000326965.6 |
TAGAP
|
T-cell activation RhoGTPase activating protein |
chr12_+_59989791 | 0.54 |
ENST00000552432.1
|
SLC16A7
|
solute carrier family 16 (monocarboxylate transporter), member 7 |
chr6_-_159466042 | 0.54 |
ENST00000338313.5
|
TAGAP
|
T-cell activation RhoGTPase activating protein |
chr4_+_81118647 | 0.54 |
ENST00000415738.2
|
PRDM8
|
PR domain containing 8 |
chr5_+_96077888 | 0.52 |
ENST00000509259.1
ENST00000503828.1 |
CAST
|
calpastatin |
chr8_+_38244638 | 0.51 |
ENST00000526356.1
|
LETM2
|
leucine zipper-EF-hand containing transmembrane protein 2 |
chr1_+_167599330 | 0.51 |
ENST00000367854.3
ENST00000361496.3 |
RCSD1
|
RCSD domain containing 1 |
chr11_-_2162162 | 0.51 |
ENST00000381389.1
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr9_-_35691017 | 0.51 |
ENST00000378292.3
|
TPM2
|
tropomyosin 2 (beta) |
chr17_+_3379284 | 0.50 |
ENST00000263080.2
|
ASPA
|
aspartoacylase |
chr22_+_45714361 | 0.47 |
ENST00000452238.1
|
FAM118A
|
family with sequence similarity 118, member A |
chr2_-_96811170 | 0.47 |
ENST00000288943.4
|
DUSP2
|
dual specificity phosphatase 2 |
chr11_-_71823796 | 0.46 |
ENST00000545680.1
ENST00000543587.1 ENST00000538393.1 ENST00000535234.1 ENST00000227618.4 ENST00000535503.1 |
ANAPC15
|
anaphase promoting complex subunit 15 |
chr1_+_28099683 | 0.46 |
ENST00000373943.4
|
STX12
|
syntaxin 12 |
chr4_-_10118469 | 0.46 |
ENST00000499869.2
|
WDR1
|
WD repeat domain 1 |
chr1_+_206858328 | 0.45 |
ENST00000367103.3
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2 |
chr1_-_208084729 | 0.44 |
ENST00000310833.7
ENST00000356522.4 |
CD34
|
CD34 molecule |
chr7_-_559853 | 0.43 |
ENST00000405692.2
|
PDGFA
|
platelet-derived growth factor alpha polypeptide |
chr4_-_109087445 | 0.42 |
ENST00000512172.1
|
LEF1
|
lymphoid enhancer-binding factor 1 |
chr17_-_4871085 | 0.42 |
ENST00000575142.1
ENST00000206020.3 |
SPAG7
|
sperm associated antigen 7 |
chr22_+_45714672 | 0.42 |
ENST00000424557.1
|
FAM118A
|
family with sequence similarity 118, member A |
chr12_+_59989918 | 0.41 |
ENST00000547379.1
ENST00000549465.1 |
SLC16A7
|
solute carrier family 16 (monocarboxylate transporter), member 7 |
chr8_-_101965146 | 0.41 |
ENST00000395957.2
ENST00000395948.2 ENST00000457309.1 |
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta |
chr5_-_111093167 | 0.41 |
ENST00000446294.2
ENST00000419114.2 |
NREP
|
neuronal regeneration related protein |
chr2_-_112237835 | 0.41 |
ENST00000442293.1
ENST00000439494.1 |
MIR4435-1HG
|
MIR4435-1 host gene (non-protein coding) |
chr20_-_62258394 | 0.41 |
ENST00000370077.1
|
GMEB2
|
glucocorticoid modulatory element binding protein 2 |
chr12_-_125398850 | 0.40 |
ENST00000535859.1
ENST00000546271.1 ENST00000540700.1 ENST00000546120.1 |
UBC
|
ubiquitin C |
chr4_-_109087872 | 0.40 |
ENST00000510624.1
|
LEF1
|
lymphoid enhancer-binding factor 1 |
chr4_-_10118573 | 0.37 |
ENST00000382452.2
ENST00000382451.2 |
WDR1
|
WD repeat domain 1 |
chr1_+_47881744 | 0.36 |
ENST00000335071.2
|
FOXE3
|
forkhead box E3 |
chr10_-_29923893 | 0.35 |
ENST00000355867.4
|
SVIL
|
supervillin |
chr3_+_63953415 | 0.34 |
ENST00000484332.1
|
ATXN7
|
ataxin 7 |
chr4_-_54930790 | 0.34 |
ENST00000263921.3
|
CHIC2
|
cysteine-rich hydrophobic domain 2 |
chr11_-_71823266 | 0.34 |
ENST00000538919.1
ENST00000539395.1 ENST00000542531.1 |
ANAPC15
|
anaphase promoting complex subunit 15 |
chr13_+_42614176 | 0.33 |
ENST00000540693.1
|
DGKH
|
diacylglycerol kinase, eta |
chr4_-_109087906 | 0.32 |
ENST00000515500.1
|
LEF1
|
lymphoid enhancer-binding factor 1 |
chr7_+_114055052 | 0.31 |
ENST00000462331.1
ENST00000408937.3 ENST00000403559.4 ENST00000350908.4 ENST00000393498.2 ENST00000393495.3 ENST00000378237.3 ENST00000393489.3 |
FOXP2
|
forkhead box P2 |
chr8_-_22550691 | 0.30 |
ENST00000519492.1
|
EGR3
|
early growth response 3 |
chr16_+_66413128 | 0.30 |
ENST00000563425.2
|
CDH5
|
cadherin 5, type 2 (vascular endothelium) |
chr12_+_62654119 | 0.29 |
ENST00000353364.3
ENST00000549523.1 ENST00000280377.5 |
USP15
|
ubiquitin specific peptidase 15 |
chr16_+_30077055 | 0.29 |
ENST00000564595.2
ENST00000569798.1 |
ALDOA
|
aldolase A, fructose-bisphosphate |
chr9_-_79520989 | 0.29 |
ENST00000376713.3
ENST00000376718.3 ENST00000428286.1 |
PRUNE2
|
prune homolog 2 (Drosophila) |
chr13_+_27825446 | 0.29 |
ENST00000311549.6
|
RPL21
|
ribosomal protein L21 |
chr7_+_143078379 | 0.28 |
ENST00000449630.1
ENST00000457235.1 |
ZYX
|
zyxin |
chr12_-_6772249 | 0.28 |
ENST00000467678.1
ENST00000493873.1 ENST00000423703.2 ENST00000412586.2 ENST00000444704.2 |
ING4
|
inhibitor of growth family, member 4 |
chr1_+_167599532 | 0.27 |
ENST00000537350.1
|
RCSD1
|
RCSD domain containing 1 |
chr16_+_56965960 | 0.27 |
ENST00000439977.2
ENST00000344114.4 ENST00000300302.5 ENST00000379792.2 |
HERPUD1
|
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 |
chr1_-_208084387 | 0.26 |
ENST00000537704.1
|
CD34
|
CD34 molecule |
chr1_+_11994715 | 0.26 |
ENST00000449038.1
ENST00000376369.3 ENST00000429000.2 ENST00000196061.4 |
PLOD1
|
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 |
chr7_+_149416439 | 0.26 |
ENST00000497895.1
|
KRBA1
|
KRAB-A domain containing 1 |
chr5_-_169816638 | 0.24 |
ENST00000521859.1
ENST00000274629.4 |
KCNMB1
|
potassium large conductance calcium-activated channel, subfamily M, beta member 1 |
chr19_-_47975417 | 0.24 |
ENST00000236877.6
|
SLC8A2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
chr2_-_106054952 | 0.24 |
ENST00000336660.5
ENST00000393352.3 ENST00000607522.1 |
FHL2
|
four and a half LIM domains 2 |
chr22_-_36850991 | 0.24 |
ENST00000442579.1
|
RP5-1119A7.14
|
RP5-1119A7.14 |
chr12_-_11548496 | 0.22 |
ENST00000389362.4
ENST00000565533.1 ENST00000546254.1 |
PRB2
PRB1
|
proline-rich protein BstNI subfamily 2 proline-rich protein BstNI subfamily 1 |
chr8_-_125827922 | 0.21 |
ENST00000533516.1
|
RP11-1082L8.4
|
RP11-1082L8.4 |
chr22_-_50216853 | 0.18 |
ENST00000342989.5
ENST00000542442.1 |
BRD1
|
bromodomain containing 1 |
chr10_-_90712520 | 0.18 |
ENST00000224784.6
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta |
chrX_+_101502170 | 0.18 |
ENST00000372757.1
|
NXF2
|
nuclear RNA export factor 2 |
chrX_-_11284095 | 0.18 |
ENST00000303025.6
ENST00000534860.1 |
ARHGAP6
|
Rho GTPase activating protein 6 |
chr22_-_36357671 | 0.17 |
ENST00000408983.2
|
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr10_-_16859442 | 0.17 |
ENST00000602389.1
ENST00000345264.5 |
RSU1
|
Ras suppressor protein 1 |
chr10_-_16859361 | 0.17 |
ENST00000377921.3
|
RSU1
|
Ras suppressor protein 1 |
chr1_-_152332480 | 0.17 |
ENST00000388718.5
|
FLG2
|
filaggrin family member 2 |
chr17_-_4890649 | 0.16 |
ENST00000361571.5
|
CAMTA2
|
calmodulin binding transcription activator 2 |
chr17_-_55911970 | 0.16 |
ENST00000581805.1
ENST00000580960.1 |
RP11-60A24.3
|
RP11-60A24.3 |
chr19_-_45826125 | 0.15 |
ENST00000221476.3
|
CKM
|
creatine kinase, muscle |
chrX_-_101694853 | 0.14 |
ENST00000372749.1
|
NXF2B
|
nuclear RNA export factor 2B |
chr19_-_47975106 | 0.13 |
ENST00000539381.1
ENST00000594353.1 ENST00000542837.1 |
SLC8A2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
chr19_+_13135439 | 0.13 |
ENST00000586873.1
|
NFIX
|
nuclear factor I/X (CCAAT-binding transcription factor) |
chr6_-_16761678 | 0.12 |
ENST00000244769.4
ENST00000436367.1 |
ATXN1
|
ataxin 1 |
chr2_-_161264385 | 0.11 |
ENST00000409972.1
|
RBMS1
|
RNA binding motif, single stranded interacting protein 1 |
chr7_-_44180884 | 0.11 |
ENST00000458240.1
ENST00000223364.3 |
MYL7
|
myosin, light chain 7, regulatory |
chr19_+_57901326 | 0.11 |
ENST00000596400.1
|
AC003002.6
|
Uncharacterized protein |
chr2_-_73520667 | 0.08 |
ENST00000545030.1
ENST00000436467.2 |
EGR4
|
early growth response 4 |
chrX_-_103499602 | 0.08 |
ENST00000372588.4
|
ESX1
|
ESX homeobox 1 |
chr2_-_106015527 | 0.07 |
ENST00000344213.4
ENST00000358129.4 |
FHL2
|
four and a half LIM domains 2 |
chr6_-_99797522 | 0.07 |
ENST00000389677.5
|
FAXC
|
failed axon connections homolog (Drosophila) |
chr16_+_4666475 | 0.06 |
ENST00000591895.1
|
MGRN1
|
mahogunin ring finger 1, E3 ubiquitin protein ligase |
chr3_+_187930719 | 0.06 |
ENST00000312675.4
|
LPP
|
LIM domain containing preferred translocation partner in lipoma |
chr2_-_208031943 | 0.06 |
ENST00000421199.1
ENST00000457962.1 |
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
chr19_+_35861831 | 0.05 |
ENST00000454971.1
|
GPR42
|
G protein-coupled receptor 42 (gene/pseudogene) |
chr14_-_94443065 | 0.05 |
ENST00000555287.1
|
ASB2
|
ankyrin repeat and SOCS box containing 2 |
chr8_+_1993152 | 0.05 |
ENST00000262113.4
|
MYOM2
|
myomesin 2 |
chr8_+_1993173 | 0.05 |
ENST00000523438.1
|
MYOM2
|
myomesin 2 |
chr10_+_96162242 | 0.03 |
ENST00000225235.4
|
TBC1D12
|
TBC1 domain family, member 12 |
chr8_-_101965559 | 0.02 |
ENST00000353245.3
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta |
chr1_+_219347186 | 0.01 |
ENST00000366928.5
|
LYPLAL1
|
lysophospholipase-like 1 |
chr12_+_62654155 | 0.01 |
ENST00000312635.6
ENST00000393654.3 ENST00000549237.1 |
USP15
|
ubiquitin specific peptidase 15 |
chr2_+_56179262 | 0.01 |
ENST00000606639.1
|
RP11-481J13.1
|
RP11-481J13.1 |
chr6_-_123958051 | 0.00 |
ENST00000546248.1
|
TRDN
|
triadin |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.8 | 50.4 | GO:0050720 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) interleukin-1 beta biosynthetic process(GO:0050720) |
1.1 | 3.3 | GO:0021571 | rhombomere 3 development(GO:0021569) rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.9 | 9.5 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.8 | 6.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.7 | 4.3 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.5 | 4.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.5 | 2.1 | GO:0009956 | radial pattern formation(GO:0009956) |
0.5 | 3.5 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.5 | 3.5 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.4 | 3.0 | GO:0008218 | bioluminescence(GO:0008218) |
0.4 | 2.8 | GO:1903921 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
0.4 | 1.2 | GO:0061145 | bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) |
0.3 | 0.9 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
0.3 | 1.1 | GO:0018277 | protein deamination(GO:0018277) |
0.2 | 3.8 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 6.0 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.2 | 1.3 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.2 | 1.5 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.2 | 1.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 0.8 | GO:0042247 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
0.2 | 0.9 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.2 | 0.5 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.2 | 2.0 | GO:0035768 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
0.2 | 4.6 | GO:0051412 | response to corticosterone(GO:0051412) |
0.2 | 1.0 | GO:1904383 | response to sodium phosphate(GO:1904383) |
0.1 | 2.8 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.6 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 8.1 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.1 | 0.8 | GO:0015853 | adenine transport(GO:0015853) |
0.1 | 1.4 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.1 | 1.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.2 | GO:1903413 | cellular response to bile acid(GO:1903413) |
0.1 | 1.0 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.1 | 1.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 0.3 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.1 | 0.3 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.1 | 0.4 | GO:0060684 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 4.8 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 5.9 | GO:0031529 | ruffle organization(GO:0031529) |
0.1 | 1.6 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 1.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.3 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.1 | 1.4 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.0 | 0.9 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.8 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.0 | 0.2 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) |
0.0 | 0.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 1.1 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 3.1 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.0 | 0.5 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 2.9 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 0.5 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.0 | 0.2 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.0 | 3.0 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.3 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.0 | 1.1 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.0 | 0.5 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 0.3 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.0 | 0.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.0 | 1.2 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 0.4 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.0 | 2.1 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.0 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 9.5 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.8 | 6.9 | GO:0035976 | AP1 complex(GO:0035976) |
0.7 | 6.0 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.3 | 2.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 6.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.2 | 1.0 | GO:0097513 | myosin II filament(GO:0097513) |
0.1 | 1.8 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 13.1 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 6.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 1.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 4.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.3 | GO:1990037 | Lewy body core(GO:1990037) |
0.0 | 0.3 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 1.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.2 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.0 | 0.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 4.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 1.7 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.7 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.6 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 3.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 3.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 2.3 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 2.0 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.7 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 1.0 | GO:0005884 | actin filament(GO:0005884) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.1 | 50.4 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.3 | 3.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 1.0 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.2 | 1.2 | GO:0010736 | serum response element binding(GO:0010736) |
0.2 | 4.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 0.8 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
0.2 | 3.5 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 1.8 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 0.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 1.8 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 2.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.6 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 10.2 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 5.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 2.8 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.1 | 9.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 1.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 2.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.3 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.1 | 5.0 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 1.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 8.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 3.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.7 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.5 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.0 | 2.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.6 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.0 | 5.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 1.1 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 1.1 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.7 | GO:0050998 | Tat protein binding(GO:0030957) nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 1.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.5 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 0.8 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 1.8 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 2.7 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 1.0 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 5.1 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 50.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 6.9 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 9.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 11.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 6.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 4.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 3.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 1.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 3.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 5.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 1.8 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 2.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 2.0 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 3.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 2.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 1.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 1.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 1.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 51.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 8.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 2.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 3.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 4.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 0.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 3.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 6.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 4.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 3.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 1.0 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 1.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 7.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 1.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 5.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 2.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 4.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.7 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.8 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |